Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. US FDA approves Amgen drug for small cell lung cancer - AOL

    www.aol.com/news/us-fda-approves-amgen-drug...

    The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...

  3. Amgen - Wikipedia

    en.wikipedia.org/wiki/Amgen

    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5]

  4. Amgen Seeks Expanded US Approval For Autoimmune Disease Drug ...

    www.aol.com/amgen-seeks-expanded-us-approval...

    On Wednesday, Amgen Inc (NASDAQ:AMGN) announced topline results from its Phase 3 trial evaluating the efficacy and safety of Uplizna (inebilizumab-cdon) for Immunoglobulin G4-related disease, a ...

  5. Celgene - Wikipedia

    en.wikipedia.org/wiki/Celgene

    Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid ( lenalidomide ), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).

  6. US FDA approves Amgen's biosimilar to AstraZeneca's rare ...

    www.aol.com/news/us-fda-approves-amgens-bio...

    Amgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex biological drugs. In 2022, the company said that Bkemv met the main goal of a late stage study, where ...

  7. Evolocumab - Wikipedia

    en.wikipedia.org/wiki/Evolocumab

    Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation; its inhibition thereby enhances the liver 's ability to remove LDL-C, often colloquially referred to as "bad" cholesterol, from the blood.

  8. Amgen Secures FDA Nod For Rare-Disease Treatment ... - AOL

    www.aol.com/finance/amgen-secures-fda-nod-rare...

    Tuesday, the FDA approved Amgen Inc (NASDAQ: AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDAQ: AZN) Soliris (eculizumab) to treat certain rare ...

  9. List of largest selling pharmaceutical products - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_selling...

    Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469 2 Ledipasvir/sofosbuvir: Harvoni Small molecule Hepatitis C: Gilead Sciences: 13,864 11,737 3 Etanercept: Enbrel Biologic Rheumatoid arthritis: Amgen. Pfizer. 8,697 4,009 4 Infliximab ...